Literature DB >> 3839068

Characteristics of human surfactant-associated glycoproteins A.

J A Whitsett, W Hull, G Ross, T Weaver.   

Abstract

Surfactant-associated glycoprotein A [molecular weight (Mr) = 34,000, isoelectric point (pI) 4.6-5.0] and its sulfhydryl dependent oligomers were purified and partially characterized from surfactant obtained from human alveolar lavage. Two major forms of the protein were identified by silver stain and immunoblot analysis of surfactant using human surfactant-associated glycoprotein A antisera: glycoprotein A2, Mr = 34,000 and glycoprotein A1, Mr = 28,000. The larger form was reduced to Mr = 28,000 by treatment with endoglycosidase F, indicating the presence of complex N-linked oligosaccharide on the molecule. Charge heterogeneity was decreased and the isoelectric point increased by treatment with neuroaminidase, supporting the presence of sialic acid. Homology between the proteins Mr = 34,000 and 28,000 was confirmed by analysis of two-dimensional tryptic and chymotryptic peptides of 125I-iodo-glycoproteins A1 and A2 which were identical. The protein was very rich in glycine and its amino acid composition was similar to that of glycoprotein A previously reported for the dog and rat. Treatment of glycoproteins A with bacterial collagenase resulted in the generation of highly glycosylated peptides Mr = 20,000-22,000, pI 4.6-5.0, which no longer formed sulfhydryl-dependent oligomers, supporting the presence of significant collagen-like region in the molecule. In the absence of reducing agents, glycoprotein A from surfactant was present as sulfhydryl-dependent dimers and larger oligomers. Higher molecular weight aggregates of glycoproteins A were also present in lavage material even after sulfhydryl reduction. Glycoproteins A were identified in surfactant from amniotic fluid, normal adult lung lavage, human cadaver lung lavage, and material obtained from lung lavage from a patient with alveolar proteinosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839068     DOI: 10.1203/00006450-198505000-00018

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

Review 1.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

2.  Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B.

Authors:  V K Sarin; S Gupta; T K Leung; V E Taylor; B L Ohning; J A Whitsett; J L Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Post-translational modification of the major human surfactant-associated proteins.

Authors:  D S Phelps; J Floros; H W Taeusch
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

4.  Detection of the type II cell or its precursor before week 20 of human gestation, using antibodies against surfactant-associated proteins.

Authors:  C J Otto-Verberne; A A Ten Have-Opbroek; J J Balkema; C Franken
Journal:  Anat Embryol (Berl)       Date:  1988

5.  The coding sequence for the 32,000-dalton pulmonary surfactant-associated protein A is located on chromosome 10 and identifies two separate restriction-fragment-length polymorphisms.

Authors:  J H Fisher; F T Kao; C Jones; R T White; B J Benson; R J Mason
Journal:  Am J Hum Genet       Date:  1987-06       Impact factor: 11.025

6.  Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

Authors:  S D Revak; T A Merritt; E Degryse; L Stefani; M Courtney; M Hallman; C G Cochrane
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

Review 7.  Review: Chemical and structural modifications of pulmonary collectins and their functional consequences.

Authors:  Elena N Atochina-Vasserman; Michael F Beers; Andrew J Gow
Journal:  Innate Immun       Date:  2010-04-27       Impact factor: 2.680

8.  cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe).

Authors:  S W Glasser; T R Korfhagen; T Weaver; T Pilot-Matias; J L Fox; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis.

Authors:  E Crouch; A Persson; D Chang; D Parghi
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

10.  Surfactant-anti-surfactant immune complexes in infants with respiratory distress syndrome.

Authors:  D S Strayer; T A Merritt; J Lwebuga-Mukasa; M Hallman
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.